Crossmark Global Holdings, Inc. Bio Rad Laboratories, Inc. Transaction History
Crossmark Global Holdings, Inc.
- $5.23 Billion
- Q2 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 1,822 shares of BIO stock, worth $615,872. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,822
Previous 1,725
5.62%
Holding current value
$615,872
Previous $597,000
16.58%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding BIO
# of Institutions
461Shares Held
19.6MCall Options Held
23.2KPut Options Held
37.4K-
Vanguard Group Inc Valley Forge, PA2.37MShares$803 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$524 Million0.01% of portfolio
-
Veritas Asset Management LLP1.13MShares$382 Million2.63% of portfolio
-
State Street Corp Boston, MA860KShares$291 Million0.01% of portfolio
-
Van Eck Associates Corp659KShares$223 Million0.26% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.33B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...